Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
MicroPort Scientific ( (HK:0853) ) has issued an update.
MicroPort Scientific Corporation reported a decrease in revenue by 2.2% for the first half of 2025, attributed to external challenges such as geopolitical tensions and market transitions. Despite these challenges, the company narrowed its losses significantly by 65.9% year-on-year, driven by reduced operational costs and strategic divestments of non-core businesses. The company is focusing on optimizing its product mix and expanding its global market presence, with a notable 57.3% growth in its international business revenue. MicroPort is also restructuring its cardiac rhythm management and structural heart disease businesses to enhance its product offerings and market influence, supported by a new strategic investor.
The most recent analyst rating on (HK:0853) stock is a Buy with a HK$17.20 price target. To see the full list of analyst forecasts on MicroPort Scientific stock, see the HK:0853 Stock Forecast page.
More about MicroPort Scientific
MicroPort Scientific Corporation is an international high-end medical device company based in China, specializing in cardiovascular devices, CRM, orthopedics devices, and surgical robots. The company has a significant market presence, with its innovative products reaching over 20,000 hospitals in more than 100 countries and regions. MicroPort leverages its global resources and experience to facilitate overseas market access and sales growth.
Average Trading Volume: 44,798,809
Technical Sentiment Signal: Buy
Current Market Cap: HK$21.9B
For detailed information about 0853 stock, go to TipRanks’ Stock Analysis page.